Science Page At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.
Oligonucleotide and Precision Therapeutics (OPT) Congress Congress ProQR presentation and panel session at the Oligonucleotide and Precision Therapeutics (OPT) Congress March 14, 2023
RNA Editing Gordon Research Conference (GRC) Presentation ProQR Presentation at the RNA Editing Gordon Research Conference (GRC) March 23, 2023
About ProQR Therapeutics Page An innovative biotech company advancing our proprietary Axiomer RNA-editing platform technology.
Leadership Page ProQR's leadership is a strong team with proven track record. Find out who is on our management team, supervisory board and scientific advisory board.
ProQR founding story Page When our CEO, Daniel A. de Boer, knew his newborn son had an incurable rare disease, he founded ProQR to help people like his son. Learn more.